Study of ctDNA as Prognostic Factor on Resectable Stage IIIA NSCLC Patients Treated With Neoadjuvant Treatment
Clinical trial NCT05382052 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05382052
- Sponsor
- Fundación GECP
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-06-17
- Primary completion
- 2026-12-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.